“ESTABLISHMENT OF THE NATIONAL TASK FORCE ON CLINICAL GOVERNANCE AND PATIENT SAFETY In furtherance of His Excellency, President Bola Ahmed Tinubu’s Renewed Hope Agenda @officialABAT, and in line with ongoing efforts to strengthen Nigeria’s health system, the Federal Ministry of Health and Social Welfare (@Fmohnigeria) has established the National Task Force on Clinical Governance and Patient Safety. The Task Force is established to support the development and operationalisation of sustainable clinical governance and patient safety structures, standards, and accountability mechanisms that improve health outcomes, enhance patient experience, and strengthen workforce performance across the Nigerian health system. The National Task Force will serve as a strategic platform for integrating quality and patient safety into all aspects of health service delivery. This initiative aligns with global calls by the World Health Organization (@WHO), the World Bank (@WorldBank), the Organisation for Economic Co-operation and Development (@OECD), and The Lancet Global Health Commission (@TheLancet) for low- and middle-income countries to move beyond access alone and prioritise high-quality, people-centred care as the foundation of Universal Health Coverage (#UHC). The work of the Task Force will contribute directly to the achievement of the Sustainable Development Goals (@SDG2030), particularly SDG 3.8 on quality essential health services, and support the realisation of the objectives of the Nigeria Health Sector Renewal Investment Initiative #NHSRII (@SWApGov). Mandate and Scope In pursuit of its objectives, the National Task Force shall undertake actions that shift the paradigm toward improvement, active learning, behavioral incentives, and capacity building, away from blame games and punitive actions when there’s no proven negligence. Accordingly, the National Task Force shall: •Conduct a national landscape analysis of clinical governance and patient safety in Nigeria •Develop and standardise national clinical governance and patient safety frameworks, policies, and implementation guidance •Strengthen systems for the prevention, reporting, learning, and response to adverse events and patient safety incidents •Promote adherence to evidence-based clinical standards, protocols, and ethical practice across health facilities •Institutionalise quality improvement and patient safety culture at facility, state, and national levels •Support capacity building for health workers and managers on clinical governance, risk management, and patient safety •Enhance patient and community engagement in quality and safety initiatives, including feedback and complaint mechanisms •Establish national indicators and monitoring systems to track quality and patient safety performance •Strengthen coordination among federal, state, regulatory, professional, and private sector stakeholders on quality and safety •Uphold confidentiality and ethical handling of sensitive information, including patient safety incidents and facility performance data Composition of the National Task Force The membership of the National Task Force on Clinical Governance and Patient Safety comprises the following: •Chair: Prof. Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare •Alternate Chair: Dr. Iziaq Adekunle Salako, @SalakoIziaq, Honourable Minister of State for Health and Social Welfare, •Daju S. Kachollom, mni – Permanent Secretary, Federal Ministry of Health and Social Welfare; •Secretary: Director, Department of Hospital Services, Federal Ministry of Health and Social Welfare; •Director, Health Planning, Research and Statistics; •Dr. Kelechi Ohiri, @k_ohiri, Director-General, National Health Insurance Authority, @nhia_nigeria •Dr. Banji Filani, @okeanaye, Chair, Forum of Honourable Commissioners of Health •Prof. Fatima Kyari – Registrar, Medical and Dental Council of Nigeria (@MDCNOfficial) •Pharm. Ibrahim Ahmed – Registrar, Pharmacy Council of Nigeria (@PCN_Registry) •Alh. Ngagi Alhassan – Registrar, Nursing and Midwifery Council of Nigeria (@NMC_Nigeria) •Registrar, Medical Laboratory Science Council of Nigeria (@MedLabNigeria) •Prof. Bala Audu – President, Nigerian Medical Association (@nationalnma) •Prof. Philip O. Abiodun – Chair, National Tertiary Health Institutions Standards Committee •Dr. Kemi Ogunyemi, PhD @kemskis, Special Adviser to the Governor of Lagos State •Prof. Gbenga Ogedegbe @GbengaOgedegbe, New York University School of Medicine (@nyuniversity) •Prof. Chinyere Anyaogu @ChichiAnyaoguMD, NYC Health + Hospitals (@NYCHealthSystem) •Prof. Joseph N. Ana – Centre for Clinical Governance Research and Patient Safety, Calabar •Dr. Toyosi Okurounmu, @ToyosiMD, Medical Leadership and Clinical Performance, Atlanta •Dr. Oranu Ibekie @oranuibekie, Indiana University School of Medicine (@IUMedSchool) •Dr. Jide Menakaya @DrJideMenakaya, President, MANSAG (@MANSAG_uk) •Dr. Sonny Isemede @sonnyisemede, Patient Safety Africa •Representative, Guild of Medical Directors •Representative, Society for Quality in Health Care in Nigeria •Mrs. Moji Makanjuola @MakanjuolaMoji, Representative of Civil Society Organisations •Representative, Association of General Medical Practitioners. Other experts may be co-opted by the Task Force as required. Members of the Task Force will contribute their expertise, experience, resources, and goodwill towards strengthening clinical governance and improving patient safety across the Nigerian health system. U. Phillip Igbinadolor, DMD FAGD President, U. Phillip Igbinadolor, DMD & Associates, P. A. P: (704) 238-8727 and (704) 494-8484. F: (704) 238-8757 and (704) 494-8483. E: uphillip@upidental.com website: www.upidental.com CONFIDENTIALITY NOTICE: All contents of this e-mail, including any attachments, are confidential and proprietary, and the sole property of U. Phillip Igbinadolor, DMD & Associates, P. A. Any duplication and/or distribution of the contents of this e-mail, not including to the dental office, without express written permission of the dental office, or any use of the contents of this e-mail in a manner that is inconsistent with the objective of this communication, is strictly prohibited. If you are not the intended recipient, please notify sender immediately by replying to the sender only and destroy all electronic and hard copies of the communication, including any attachments.